Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil

Por Barros, Fabio MR, Cheinquer, Hugo, Tsuchiya, Carolina T, Santos, Eduardo AV
Publicado em 2013

A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C

Por Flisiak, Robert, Shiffman, Mitchell, Arenas, Juan, Cheinquer, Hugo, Nikitin, Igor, Dong, Yuping, Rana, Khurram, Srinivasan, Subasree
Publicado no PLoS One (2016)

The use of ustekinumab in a patient with severe psoriasis and positive HBV serology()

Por Steglich, Raquel Bissacotti, Meneghello, Luana Pizarro, de Carvalho, André Vicente Esteves, Cheinquer, Hugo, Muller, Fernanda Melo, Reginatto, Flávia Pereira
Publicado em 2014

52-Week Efficacy and Safety of Telbivudine with Conditional Tenofovir Intensification at Week 24 in HBeAg-Positive Chronic Hepatitis B

Por Piratvisuth, Teerha, Komolmit, Piyawat, Tanwandee, Tawesak, Sukeepaisarnjaroen, Wattana, Chan, Henry L. Y., Pessôa, Mário G., Fassio, Eduardo, Ono, Suzane K., Bessone, Fernando, Daruich, Jorge, Zeuzem, Stefan, Cheinquer, Hugo, Pathan, Rashidkhan, Dong, Yuhong, Trylesinski, Aldo
Publicado em 2013